TrialStem cell research & therapy2023

Intravitreal allogeneic mesenchymal stem cells: a non-randomized phase II clinical trial for acute non-arteritic optic neuropathy.

Jose C Pastor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.